Related Experiment Video

Updated: May 8, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Mitochondria: a promising target for anticancer alkaloids

Félix A Urra1, Miguel Cordova-Delgado, Hernan Pessoa-Mahana

  • 1Department of Organic and Physical Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago de Chile. raraya@ciq.uchile.cl.

Current Topics in Medicinal Chemistry
|August 28, 2013
PubMed

Insights

Alkaloids show promise in cancer research by targeting tumor mitochondria. These compounds affect mitochondrial functions, offering new avenues for developing novel anticancer drugs and therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Alkaloids are a significant class of compounds with demonstrated anticancer potential.
  • Mitochondria play a crucial role in tumor progression, including resistance to cell death and proliferation.
  • Targeting mitochondrial functions presents a promising strategy for cancer therapy.

Purpose of the Study:

  • To review the multifaceted roles of alkaloids in targeting tumor mitochondria.
  • To highlight mitochondria as a key organelle in the anticancer mechanisms of alkaloids.
  • To underscore the importance of mitochondria in medicinal chemistry for cancer drug development.

Main Methods:

  • Literature review of studies investigating alkaloid interactions with tumor mitochondria.
  • Analysis of alkaloids' effects on mitochondrial functions such as OXPHOS, ROS production, and apoptosis.
  • Examination of alkaloids' impact on mitochondrial morphology, biogenesis, and metabolic pathways.

Main Results:

  • Alkaloids modulate mitochondrial oxidative phosphorylation (OXPHOS) and ADP/ATP transport.
  • Many alkaloids increase reactive oxygen species (ROS) levels and dissipate mitochondrial potential.
  • Alkaloids induce mitochondria-dependent apoptosis and autophagy, and inhibit mitochondrial metabolic pathways.

Conclusions:

  • Mitochondria are central targets for the anticancer activities of various alkaloids.
  • Alkaloid-induced mitochondrial dysfunction offers a promising strategy for novel anticancer drug design.
  • Further research into organelle-specific delivery strategies for alkaloid derivatives is warranted.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...